THROMBOLYSIS OF THE OCCLUDED PROSTHETIC GRAFT WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR - TECHNIQUE, RESULTS AND PROBLEMS IN 23 PATIENTS

被引:6
|
作者
GUEST, P [1 ]
BUCKENHAM, T [1 ]
机构
[1] ST GEORGE HOSP,DEPT RADIOL,LONDON,ENGLAND
关键词
D O I
10.1016/S0009-9260(05)80683-X
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Over a 12 month period all patients but one presenting to our hospital with occluded prosthetic grafts were treated by thrombolysis using local pulsed administration of tissue-type plasminogen activator (t-PA). There were 30 interventions in 23 patients but in one patient no thrombolytic was given after aspiration of pus from the graft. Thrombolysis was attempted in the remaining 29 procedures. 22/29 (76%) of these procedures were performed by direct puncture and catheterization of the occluded graft and in a further six (21%) access was from a non-occluded femoral artery or graft. In one case the graft was accessed surgically. Supplementary angioplasties were performed in 15 cases (52%). Complications requiring surgery occurred in four (14%) with a further seven minor complications. There were no deaths. A lower rate of complications occurred in the grafts entered by direct puncture. Thrombolysis was achieved in all but one case taking an average of only 2.5 h but was only maintained beyond the end of the procedure in 21/29 (72%). An underlying cause for occlusion was identified and treated where possible, e.g. haematological or clotting abnormalities or inflow or outflow stenoses. There was a high rate of reocclusion but with repeat procedures when necessary patency was maintained in 10/22 patients (45%) on follow-up at 1 to 12 months. The best results were obtained with lysis of occluded femoro-femoral crossover grafts.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
  • [31] EFFECTS OF THERAPEUTIC DOSES OF HEPARIN ON THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN RABBITS
    AGNELLI, G
    PASCUCCI, C
    COSMI, B
    NENCI, GG
    BLOOD, 1990, 76 (10) : 2030 - 2036
  • [32] REQUIREMENT OF HEPARIN FOR ARTERIAL AND VENOUS THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    RAPOLD, HJ
    LU, HR
    WU, ZM
    NIJS, H
    COLLEN, D
    BLOOD, 1991, 77 (05) : 1020 - 1024
  • [33] THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - PARADOXICAL INVIVO AND INVITRO EFFECTS
    TOPOL, EJ
    BELL, WR
    BRINKER, JA
    GOTTLIEB, SO
    BRIN, KP
    COLLEN, D
    CIRCULATION, 1984, 70 (04) : 365 - 365
  • [34] LACK OF INTERFERENCE BY HEPARIN WITH THROMBOLYSIS OR BINDING OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR TO THROMBI
    FRY, ETA
    SOBEL, BE
    BLOOD, 1988, 71 (05) : 1347 - 1352
  • [35] RENAL-ARTERY EMBOLISM - THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    MUGGE, A
    GULBA, DC
    FREI, U
    WAGENBRETH, I
    GROTE, R
    DANIEL, WG
    LICHTLEN, PR
    JOURNAL OF INTERNAL MEDICINE, 1990, 228 (03) : 279 - 286
  • [36] COMPLETE THROMBOLYSIS OF MESENTERIC VEIN OCCLUSION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    ROBIN, P
    GRUEL, Y
    LANG, M
    LAGARRIGUE, F
    SCOTTO, JM
    LANCET, 1988, 1 (8599): : 1391 - 1391
  • [37] IMPROVED THROMBOLYSIS WITH A MODIFIED DOSE REGIMEN OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    NEUHAUS, KL
    FEUERER, W
    JEEPTEBBE, S
    NIEDERER, W
    VOGT, A
    TEBBE, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (06) : 1566 - 1569
  • [39] THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN RENAL VENOUS THROMBOSIS IN INFANCY
    NOWAKGOTTL, U
    SCHWABE, D
    SCHNEIDER, W
    SCHLOSSER, R
    KREUZ, W
    LANCET, 1992, 340 (8827): : 1105 - 1105
  • [40] CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) IN EXPERIMENTAL-MODEL
    KANMATSUSE, K
    KAJIWARA, N
    SATOH, Y
    SETO, H
    IWASAKI, M
    OHBA, T
    YUMI, K
    WATANABE, I
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (06): : 552 - 552